Industry News
Killing leukemia cells by disrupting their metabolism doesn't harm normal cells
Sep 15, 2014
A study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant to shifts in their energy supply than their normal counterparts. Read More
Relationship between the diversity of gut bacteria and future risk of developing breast cancer
Sep 15, 2014
Postmenopausal women with diverse gut bacteria exhibit a more favorable ratio of estrogen metabolites, which is associated with reduced risk for breast cancer, compared to women with less microbial... Read More
Small cell lung cancer: chest radiotherapy 'prolongs survival, reduces recurrence'
Sep 15, 2014
Chest radiation therapy, in combination with standard treatment, may reduce recurrence and prolong survival in patients with small cell lung cancer, according to a phase 3 trial. Read More
'Electronic skin' could revolutionize breast cancer detection
Sep 15, 2014
Scientists are developing an 'electronic skin' that could detect and image small lumps that are currently undetectable by clinicians. Read More
Using MRI and PET to monitor the response to treatment in bone metastases
Sep 15, 2014
A review and position statement of the EORTC Imaging GroupImaging technologies are very useful in evaluating a patient's response to cancer treatment, and this can be done quite effectively for... Read More
Nintedanib in combination with paclitaxel achieves total remission of tumors in 50 percent of HER-2-negative breast cancer patients
Sep 14, 2014
The experimental drug nintedanib, combined with standard chemotherapy with paclitaxel, causes a total remission of tumours in 50% of patients suffering from early HER-2- negative breast cancer, the... Read More
Improved survival of ovarian cancer patients receiving treatment guided by comprehensive tumour profiling
Sep 12, 2014
Data from an ovarian cancer registry presented at the European Society for Gynaecological Oncology (ESGO) annual meeting reinforce comprehensive tumour profiling as a 'game changer' for oncologists. Read More
Genomic analysis reveals that a high-risk leukemia subtype becomes more common with age
Sep 12, 2014
More than one-quarter of young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and may benefit from drugs widely used to treat... Read More
Improved survival of ovarian cancer patients receiving treatment guided by comprehensive tumour profiling
Sep 12, 2014
Data from an ovarian cancer registry presented at the European Society for Gynaecological Oncology (ESGO) annual meeting reinforce comprehensive tumour profiling as a 'game changer' for oncologists. Read More
Genomic analysis reveals that a high-risk leukemia subtype becomes more common with age
Sep 12, 2014
More than one-quarter of young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and may benefit from drugs widely used to treat... Read More
Previous Page Next Page